Arkolith/Insider Trading/ADIL/Form 4

Truluck Joseph

Chief Financial OfficerADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed May 25, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 23, 2023Grant(A)158K—$0265K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 23, 2023Grant(A)125K—$0125K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-043133) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML